RoundTable Healthcare Partners has invested in Colorescience, a skincare and sun protection brand, acquiring the company from a shareholder group led by 1315 Capital. Colorescience represents the third platform investment from RoundTable’s current equity fund and adds to its consumer healthcare portfolio.
Founded in 2013, Colorescience develops mineral-based skincare and sun protection products used daily by consumers and recommended by dermatologists, plastic surgeons, aestheticians, and medical spas. The company sells through professional providers, direct-to-consumer channels, and major e-commerce platforms. Mary Fisher serves as chief executive officer, and the company is headquartered in Carlsbad, California.
Leading the transaction for RoundTable were Tim Connors and Jawwad Akhtar. “We could not be more excited to partner with Mary and the entire Colorescience management team,” said Mr. Connors. “Colorescience has built a compelling platform defined by strong consumer advocacy and a differentiated product portfolio anchored by a commitment to science and innovation. We look forward to supporting the team as they continue to advance the Colorescience brand and capitalize on the company’s momentum.”
Colorescience is RoundTable’s third platform for its $800 million Equity Fund VI. Senior debt financing was provided by Capital One, CIBC Bank USA and Lord Abbett Private Credit. Raymond James was the financial advisor to Colorscience.
